Press Releases
SAN FRANCISCO, Jan. 8, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has developed a technology to extend canine antibody half-life by up to three-fold. A patent application for this technology has been filed.
Read more...Alkermes\' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference
8 January 2020
DUBLIN, Jan. 8, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its corporate presentation will be webcast live at the 38th Annual J.P. Morgan Healthcare
Read more...ST. LOUIS, Jan. 8, 2020 /PRNewswire/ -- Healthy Hives 2020, a multi-year, $1.3 million research initiat
Read more...WASHINGTON, Jan. 8, 2020 /PRNewswire/ -- On Thursday, January 9, 2020, at 10:00 a.m. ET, MAZON: A Jewish Response to Hun
Read more...NORTHBROOK, Ill., Jan. 8, 2020 /PRNewswire/ -- Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for MYCAMINE® (micafungin for injection) in support of the treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses witho
Read more...MISSION VIEJO, Calif., Jan. 8, 2020 /PRNewswire/ -- BENEV Company Inc®, an FDA Registered cosmeceutical manufacturer, and globally recognized medical professional line, announced on Nov 1st, 2019 the formation of their Medical Advisory Board comprised of five experts in the aesthetic arena, who are faculty at world-l
Read more...MISSION VIEJO, Calif., Jan. 8, 2020 /PRNewswire/ -- DBM Corporation Inc® the Official Representative of MIRACU PDO THREADS® in the US, Canada, and Mexico® announced on Nov 1st, 2019 the formation of their Medical Adv
Read more...LEE'S SUMMIT, Mo., Jan. 8, 2020 /PRNewswire/ -- Viracor Eurofins, a leading U.S. transplant diagnostics laboratory, announced it has begun offering a proprietary donor derived cell-free DNA (dd-cfDNA) assay, Viracor TRAC™, to complement its suite of testing supporting successful outcomes for those patients with kidney transplants.
Read more...8 January 2020
PRINCETON, N.J., Jan. 8, 2020 /PRNewswire/ -- Guerbet, a global specialist in contrast agents and solutions for medical imaging, announced today that Thomas McLaughlin has been appointed Vice President, North America. In this role, McLaughlin will oversee and ensure the growth of Guerbet diagnostic and inter
Read more...ORLANDO, Fla., Jan. 8, 2020 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end
Read more...